Vertaling van "the famhp has approved " (Nederlands → Frans) :

If no comments have been received within this timeframe, it is tacitly assumed that the FAMHP has approved the commencement of the clinical trial.
If no comments have been received within this timeframe, it is tacitly assumed that the FAMHP has approved the commencement of the clinical trial.

At present there are five agents who belong to the internal FAMHP team and ten agents who are supplied by the ICT service of the FPS Public Health, with which an SLA has been concluded in order to bring to a successful conclusion the transfer of tools and IT skills from the former DG Medicinal Products to the FAMHP and ensure the continuity of service provision.
At present there are five agents who belong to the internal FAMHP team and ten agents who are supplied by the ICT service of the FPS Public Health, with which an SLA has been concluded in order to bring to a successful conclusion the transfer of tools and IT skills from the former DG Medicinal Products to the FAMHP and ensure the continuity of service provision.

In addition, as an exceptional measure under the law on the formation of the FAMHP, the “Medicine Fund’s account” balance of 27,534,000 euros has been transferred from the State to the FAMHP.
In addition, as an exceptional measure under the law on the formation of the FAMHP, the “Medicine Fund’s account” balance of 27,534,000 euros has been transferred from the State to the FAMHP.

The FAMHP has regulated the distribution sector by ensuring the registration of all distributors and publishing the list of recognised distributors on the FAMHP website.
The FAMHP has regulated the distribution sector by ensuring the registration of all distributors and publishing the list of recognised distributors on the FAMHP website.

The data in this source need, of course, to agree with those that have been approved or determined by the competent authority for marketing authorisation – MA (FAMHP), price (FPS Economy) and reimbursement modalities (RIZIV-INAMI), respectively.
The data in this source need, of course, to agree with those that have been approved or determined by the competent authority for marketing authorisation – MA (FAMHP), price (FPS Economy) and reimbursement modalities (RIZIV-INAMI), respectively.

On 23 December 2005, approval was granted by the Council of Ministers for the establishment of an autonomous medicines agency: the Federal Agency for Medicines and Health Products or FAMHP.
On 23 December 2005, approval was granted by the Council of Ministers for the establishment of an autonomous medicines agency: the Federal Agency for Medicines and Health Products or FAMHP.

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.

Gleevec/Glivec, a targeted therapy for certain forms of CML and GIST, was approved in 2009 for use in adjuvant GIST and has since received approvals for this indication in more than 55 countries.
Glivec/Gleevec, un traitement ciblé contre certaines formes de LMC et de GIST, a été homologué en 2009 pour son utilisation comme adjuvant dans les GIST et a depuis été autorisé pour cette indication dans plus de 55 pays.

Gleevec/Glivec, a targeted therapy for certain forms of CML and GIST, was approved in 2009 for use in adjuvant treatment of patients following complete gross resection of GIST and has since received approvals for this indication in more than 55 countries.
Glivec/Gleevec, un traitement ciblé contre certaines formes de LMC et de GIST, a été homologué en 2009 pour son utilisation comme adjuvant dans les résections complètes de GIST et a depuis été autorisé pour cette indication dans plus de 55 pays.

Our oncology franchise continues to expand its portfolio, as Tasigna (an improved therapy over Glivec) has received recommendation for approval in the EU and approval in Switzerland as a first-line treatment for patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), a form of blood cancer.
Domaine thérapeutique stratégique, Oncologie continue d’étendre son portefeuille: Tasigna, qui représente une amélioration par rapport à Glivec, a reçu des avis favorables à une homologation par l’UE et a été autorisé en Suisse en tant que traitement de première ligne de la leucémie myéloïde chronique à chromosome Philadelphie positif (LMC Ph+), une forme du cancer du sang.